<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d435">
    <sentence id="DDI-DrugBank.d435.s0" text="Exemestane is extensively metabolized by CYP 3A4, but coadministration of ketoconazole, a potent inhibitor of CYP 3A4, has no significant effect on exemestane pharmacokinetics.">
        <entity id="DDI-DrugBank.d435.s0.e0" charOffset="0-9"
            type="drug" text="Exemestane"/>
        <entity id="DDI-DrugBank.d435.s0.e1" charOffset="74-85"
            type="drug" text="ketoconazole"/>
        <entity id="DDI-DrugBank.d435.s0.e2" charOffset="148-157"
            type="drug" text="exemestane"/>
        <pair id="DDI-DrugBank.d435.s0.p0" e1="DDI-DrugBank.d435.s0.e0"
            e2="DDI-DrugBank.d435.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d435.s0.p1" e1="DDI-DrugBank.d435.s0.e0"
            e2="DDI-DrugBank.d435.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d435.s0.p2" e1="DDI-DrugBank.d435.s0.e1"
            e2="DDI-DrugBank.d435.s0.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d435.s1" text="Significant pharmacokinetic interactions mediated by inhibition of CYP isoenzymes therefore appear unlikely."/>
    <sentence id="DDI-DrugBank.d435.s2" text="Co-medications that induce CYP 3A4 (e.g., rifampicin, phenytoin, carbamazepine, phenobarbital, or St. John s wort) may significantly decrease exposure to exemestane.">
        <entity id="DDI-DrugBank.d435.s2.e0" charOffset="42-51"
            type="drug" text="rifampicin"/>
        <entity id="DDI-DrugBank.d435.s2.e1" charOffset="54-62"
            type="drug" text="phenytoin"/>
        <entity id="DDI-DrugBank.d435.s2.e2" charOffset="65-77"
            type="drug" text="carbamazepine"/>
        <entity id="DDI-DrugBank.d435.s2.e3" charOffset="80-92"
            type="drug" text="phenobarbital"/>
        <entity id="DDI-DrugBank.d435.s2.e4" charOffset="154-163"
            type="drug" text="exemestane"/>
        <pair id="DDI-DrugBank.d435.s2.p0" e1="DDI-DrugBank.d435.s2.e0"
            e2="DDI-DrugBank.d435.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d435.s2.p1" e1="DDI-DrugBank.d435.s2.e0"
            e2="DDI-DrugBank.d435.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d435.s2.p2" e1="DDI-DrugBank.d435.s2.e0"
            e2="DDI-DrugBank.d435.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d435.s2.p3" e1="DDI-DrugBank.d435.s2.e0"
            e2="DDI-DrugBank.d435.s2.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d435.s2.p4" e1="DDI-DrugBank.d435.s2.e1"
            e2="DDI-DrugBank.d435.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d435.s2.p5" e1="DDI-DrugBank.d435.s2.e1"
            e2="DDI-DrugBank.d435.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d435.s2.p6" e1="DDI-DrugBank.d435.s2.e1"
            e2="DDI-DrugBank.d435.s2.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d435.s2.p7" e1="DDI-DrugBank.d435.s2.e2"
            e2="DDI-DrugBank.d435.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d435.s2.p8" e1="DDI-DrugBank.d435.s2.e2"
            e2="DDI-DrugBank.d435.s2.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d435.s2.p9" e1="DDI-DrugBank.d435.s2.e3"
            e2="DDI-DrugBank.d435.s2.e4" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d435.s3" text="Dose modification is recommended for patients who are also receiving a potent CYP 3A4 inducer."/>
    <sentence id="DDI-DrugBank.d435.s4" text="Drug/Laboratory Tests Interactions No clinically relevant changes in the results of clinical laboratory tests have been observed."/>
</document>
